- Report
- February 2026
- 456 Pages
Global
From €4436EUR$4,950USD£3,867GBP
- Report
- September 2025
- 150 Pages
Global
From €5332EUR$5,950USD£4,649GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- July 2025
- 43 Pages
United States
From €1080EUR$1,205USD£941GBP
- Report
- May 2023
- 147 Pages
Global
From €4435EUR$4,949USD£3,867GBP
- Report
- March 2024
- 100 Pages
North America
€4477EUR$4,995USD£3,902GBP
- Report
- February 2024
- 97 Pages
Global
From €3500EUR$4,183USD£3,158GBP
The Clinical Reference Laboratory market is an important part of the Drug Discovery process. It provides a range of services to support the development of new drugs, including testing for safety and efficacy, as well as the analysis of clinical samples. These services are essential for the development of new drugs, as they provide the data needed to assess the safety and efficacy of a drug before it is approved for use.
The Clinical Reference Laboratory market is highly competitive, with a number of companies offering a range of services. These companies include Quest Diagnostics, LabCorp, Eurofins Scientific, Charles River Laboratories, and Bio-Rad Laboratories. Each of these companies provides a range of services, from sample collection and analysis to data analysis and reporting. Show Less Read more